Duvelisib

Duvelisib is a medication used in cancer treatment, specifically for certain types of blood cancers such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It works by targeting and inhibiting specific proteins involved in cancer cell growth and survival, which helps to slow down or stop the progression of the disease. Approved by regulatory authorities, duvelisib is an oral treatment option, allowing patients to take it at home rather than receiving it through intravenous infusion. As with all medications, it may come with potential side effects, and its use is guided by healthcare professionals.